We are live on
!
Find out more
SELLAS Life Sciences
15 hedge funds and large institutions have $722K invested in SELLAS Life Sciences in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
36% more funds holding
Funds holding: 11 → 15 (+4)
1.78% less ownership
Funds ownership: 7.99% → 6.21% (-1.8%)
57% less capital invested
Capital invested by funds: $1.67M → $722K (-$950K)
Holders
15
Holders Change
+4
Holders Change %
+36.36%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$85.4K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$50.1K |
| 3 |
Bank of New York Mellon
New York
|
+$41.5K |
| 4 |
WG
Winton Group
London,
United Kingdom
|
+$20.2K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$5.92K |
Top Sellers
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$178K |
| 2 |
LI
Leap Investments
Chicago,
Illinois
|
-$47K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.78K |